CNSL vs. MXC, PRM, TLY, BVX, LLAI, IMM, INHC, STX, POLX, and CHLL
Should you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Argent BioPharma (MXC), Proteome Sciences (PRM), Totally (TLY), BiVictriX Therapeutics (BVX), LungLife AI (LLAI), ImmuPharma (IMM), Induction Healthcare Group (INHC), Shield Therapeutics (STX), Polarean Imaging (POLX), and Chill Brands Group (CHLL). These companies are all part of the "medical" sector.
Cambridge Nutritional Sciences (LON:CNSL) and Argent BioPharma (LON:MXC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, community ranking, earnings, risk, media sentiment, analyst recommendations and institutional ownership.
1.7% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are owned by institutional investors. 9.2% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 8.2% of Argent BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Cambridge Nutritional Sciences has higher revenue and earnings than Argent BioPharma. Cambridge Nutritional Sciences is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.
Argent BioPharma has a net margin of 0.00% compared to Cambridge Nutritional Sciences' net margin of -27.32%. Argent BioPharma's return on equity of 0.00% beat Cambridge Nutritional Sciences' return on equity.
In the previous week, Argent BioPharma had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for Argent BioPharma and 0 mentions for Cambridge Nutritional Sciences. Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Argent BioPharma'saverage media sentiment score.
Cambridge Nutritional Sciences and Argent BioPharma both received 0 outperform votes by MarketBeat users.
Cambridge Nutritional Sciences has a beta of 3.87, suggesting that its stock price is 287% more volatile than the S&P 500. Comparatively, Argent BioPharma has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500.
Summary
Cambridge Nutritional Sciences beats Argent BioPharma on 7 of the 12 factors compared between the two stocks.
Get Cambridge Nutritional Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNSL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Nutritional Sciences Competitors List
Related Companies and Tools
